| 1 |
28403626 | Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes. | 2019 Sep |
1 |
| 2 |
28975318 | In PCI-treated ACS, switching from aspirin + a newer P2Y12 blocker to aspirin + clopidogrel reduced adverse events. | 2017 Sep 19 |
1 |
| 3 |
30650477 | [Correlation between CYP2C19 Gene Polymorphism with Clopidogrel Resistance and Distribution of Chinese Medicine Syndrome in 229 Acute Coronary Syndrome Patients]. | 2017 Mar |
2 |
| 4 |
27249437 | [THE FIRST RESULTS OF THE PREVALENCE OF CYP2C19 GENEPOLYMORPHISM IN PATIENTS WITH ACUTE CORONARY SYNDROME IN THE AKTYUBINSK POPULATION]. | 2016 Apr |
1 |
| 5 |
27459657 | Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis. | 2016 Aug |
1 |
| 6 |
25896573 | Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis. | 2015 Apr |
1 |
| 7 |
24362676 | Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: an in vitro pharmacodynamic investigation. | 2014 Feb |
1 |
| 8 |
24952863 | Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial. | 2014 Jul |
1 |
| 9 |
25218311 | Point-of-care measurements of platelet inhibition after clopidogrel loading in patients with acute coronary syndrome: comparison of generic and branded clopidogrel bisulfate. | 2014 Nov 1 |
1 |
| 10 |
25634391 | Safety of Prasugrel in Indian patients - multicentric registry of 1000 cases. | 2014 Nov-Dec |
1 |
| 11 |
22721490 | Clopidogrel resistance in North Indian patients of coronary artery disease and lack of its association with platelet ADP receptors P2Y1 and P2Y12 gene polymorphisms. | 2013 |
2 |
| 12 |
23084816 | Platelet reactivity in diabetic patients undergoing coronary stenting for acute coronary syndrome treated with clopidogrel loading dose followed by prasugrel maintenance therapy. | 2013 Sep 20 |
1 |
| 13 |
23474908 | Cost-effectiveness of ticagrelor versus clopidogrel for the prevention of atherothrombotic events in adult patients with acute coronary syndrome in Germany. | 2013 Jun |
1 |
| 14 |
23735342 | Mortality after clopidogrel in the non-invasive PLATO cohort and TRILOGY ACS trial: another mismatched death paradox. | 2013 Sep 30 |
1 |
| 15 |
24070598 | Impact of initial clinical presentation on clopidogrel low response. | 2013 Nov |
3 |
| 16 |
22739809 | Antiplatelet therapy - ticagrelor. | 2012 |
1 |
| 17 |
22792485 | Impact of dual antiplatelet therapy with proton pump inhibitors on the outcome of patients with acute coronary syndrome undergoing drug-eluting stent implantation. | 2012 |
1 |
| 18 |
22965108 | Comparison of prasugrel and clopidogrel in the setting of ACS without revascularization. | 2012 Nov |
1 |
| 19 |
21256376 | Double-dose clopidogrel in patients undergoing PCI for ACS. | 2011 Jan 22 |
1 |
| 20 |
21256377 | Double-dose clopidogrel in patients undergoing PCI for ACS. | 2011 Jan 22 |
1 |
| 21 |
20598967 | Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial. | 2010 Jul |
1 |
| 22 |
18611364 | Should Prasugrel or Clopidogrel Be Used in Patients with ACS? | 2008 Jul |
1 |
| 23 |
17180146 | Is clopidogrel associated with poor outcome in patients with non-ST-segment elevation ACS after early CABG surgery? | 2007 Jan |
1 |
| 24 |
17337040 | Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome. | 2007 |
1 |
| 25 |
17938809 | ADP-induced platelet aggregation and platelet reactivity index VASP are good predictive markers for clinical outcomes in non-ST elevation acute coronary syndrome. | 2007 Oct |
3 |
| 26 |
16843176 | Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. | 2006 Jul 18 |
2 |
| 27 |
17010792 | Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. | 2006 Oct 3 |
1 |
| 28 |
12464982 | Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes. | 2002 Nov |
1 |
| 29 |
11520515 | Clopidogrel in invasive management of non-ST-elevation ACS. | 2001 Aug 18 |
1 |